BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

AngioGenex Inc. 

425 Madison Avenue
Suite 902)
New York  New York  10017  U.S.A.
Phone: 212-874-6608 Fax: 212-874-5027


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences 2/3/2009 1:19:16 PM    More...
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009 11/26/2008 8:11:57 AM    More...
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 6/10/2008 8:44:53 AM    More...
Benezra Report in Nature Biotechnology Validates AngioGenex's Drug Development Platform by Demonstrating Tumor Suppression Through Id Protein Inhibition 1/8/2008 10:36:00 AM    More...
William Garland Joins AngioGenex's New Board of Directors 1/7/2008 10:47:03 AM    More...
AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer 10/16/2007 8:42:47 AM    More...
AngioGenex European Listing Approved -- Company's Shares Now Trading on the Frankfurt Stock Exchange under Symbol 'TLE' 6/21/2007 11:48:51 AM    More...
AngioGenex Engages London & Pacific Healthcare to Assist in Attracting Investment Funding 5/4/2007 10:43:49 AM    More...
AngioGenex, BioCheck Collaboration Produces Novel Antibodies, Revenue and Progress toward a Cancer Diagnostic 5/3/2007 12:48:25 PM    More...
AngioGenex Listing Approved-Trading Under Symbol AGGX.OB 3/7/2007 2:13:37 PM    More...
12

//-->